JP2006517520A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517520A5
JP2006517520A5 JP2004557689A JP2004557689A JP2006517520A5 JP 2006517520 A5 JP2006517520 A5 JP 2006517520A5 JP 2004557689 A JP2004557689 A JP 2004557689A JP 2004557689 A JP2004557689 A JP 2004557689A JP 2006517520 A5 JP2006517520 A5 JP 2006517520A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
peptide
composition according
peptide according
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004557689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517520A (ja
Filing date
Publication date
Priority claimed from BRPI0205449-3A external-priority patent/BR0205449A/pt
Application filed filed Critical
Publication of JP2006517520A publication Critical patent/JP2006517520A/ja
Publication of JP2006517520A5 publication Critical patent/JP2006517520A5/ja
Pending legal-status Critical Current

Links

JP2004557689A 2002-12-09 2003-12-09 蛇、特にジャララカの毒腺から分泌されたペプチド類、バソぺプチダーゼ阻害薬、evasin類、それらの類似体および誘導体からなる薬学組成物の製造法、および用途開発のための関連製品および晩成退行性疾病での使用 Pending JP2006517520A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0205449-3A BR0205449A (pt) 2002-12-09 2002-12-09 composições farmacêuticas de peptìdeos, secretados pelas glándulas do veneno de serpentes, particurlamente da bothrops jararaca, inibidores de vasopeptidases, evasins, seus análogos, derivaados e produtos associados para o desenvolvimento de aplicações e uso em doenças crÈnico-degenerativas
PCT/BR2003/000192 WO2004052273A2 (en) 2002-12-09 2003-12-09 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands

Publications (2)

Publication Number Publication Date
JP2006517520A JP2006517520A (ja) 2006-07-27
JP2006517520A5 true JP2006517520A5 (cg-RX-API-DMAC7.html) 2007-02-01

Family

ID=32476825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004557689A Pending JP2006517520A (ja) 2002-12-09 2003-12-09 蛇、特にジャララカの毒腺から分泌されたペプチド類、バソぺプチダーゼ阻害薬、evasin類、それらの類似体および誘導体からなる薬学組成物の製造法、および用途開発のための関連製品および晩成退行性疾病での使用

Country Status (9)

Country Link
US (1) US20080199503A1 (cg-RX-API-DMAC7.html)
EP (1) EP1581550A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006517520A (cg-RX-API-DMAC7.html)
CN (1) CN1820018B (cg-RX-API-DMAC7.html)
AU (1) AU2003302871A1 (cg-RX-API-DMAC7.html)
BR (1) BR0205449A (cg-RX-API-DMAC7.html)
CA (1) CA2507980A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05006170A (cg-RX-API-DMAC7.html)
WO (1) WO2004052273A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010538991A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのsfllr−ohおよびムラミルジペプチドの使用
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
WO2012138710A2 (en) 2011-04-07 2012-10-11 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios
EP4229164A1 (en) 2020-10-16 2023-08-23 The Procter & Gamble Company Consumer product compositions with at least two encapsulate populations
JP7719177B2 (ja) 2020-10-16 2025-08-05 ザ プロクター アンド ギャンブル カンパニー 封入体の集団を含む消費者製品組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0101088A (pt) * 2001-03-19 2003-03-18 Biolab Sanus Farmaceutica Ltda Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.

Similar Documents

Publication Publication Date Title
AU737092B2 (en) Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
US6087386A (en) Composition of enalapril and losartan
RU2398588C2 (ru) Комбинация, содержащая n-(3-метокси-5-метилпиразин-2-ил)-2-(4-[1,3,4-оксадиазол-2-ил]фенил)пиридин-3-сульфонамид и lhrh-аналог и/или бифосфонат
TW200306799A (en) Combination of organic compounds
NZ552558A (en) Compositions for delivering peptide YY and PYY agonists
RU2009110452A (ru) Галеновые составы алискирена
JP2004514703A (ja) 有機化合物の組合せ剤
Ruilope et al. Eprosartan versus enalapril in elderly patients with hypertension: a doubleblind, randomized trial
JP2024523559A5 (cg-RX-API-DMAC7.html)
AU724576B2 (en) A composition of enalapril and losartan
JP2002530353A5 (cg-RX-API-DMAC7.html)
KR20090047424A (ko) 굴심방 결절 If 전류 억제제와 앤지오텐신 전환 효소 억제제의 회합체, 및 이를 함유한 약제 조성물
WO2004006929A1 (ja) 経鼻吸収用組成物
HUP9900227A2 (hu) AII-receptor antagonisták új gyógyszerészeti felhasználása
AU2009218060B2 (en) Pharmaceutical composition for transnasal administration
KR20000076211A (ko) 택산과 조합된 돌라스태틴-15 유도체
WO2008101375A1 (en) A gastric retentive sustained-release pharmaceutical composition comprising irbesartan
JP2010535212A (ja) 改良されたカンデサルタンの製剤
JP2006517520A (ja) 蛇、特にジャララカの毒腺から分泌されたペプチド類、バソぺプチダーゼ阻害薬、evasin類、それらの類似体および誘導体からなる薬学組成物の製造法、および用途開発のための関連製品および晩成退行性疾病での使用
JP4599714B2 (ja) 経口吸収改善医薬用組成物
CN102898506A (zh) Rpak/咪唑啉/rgd三元缀合物及其制备方法和用途
CN101669957B (zh) 一种乐卡地平与贝那普利的药物组合及其应用
JPWO2000043041A1 (ja) 経口吸収改善医薬用組成物
JPH09502427A (ja) オキシトシン拮抗薬活性を示すペプチド
CN107072977B (zh) Nep抑制剂药物组合及其应用